PT-141 10mg
A 10mg lyophilised synthetic cyclic heptapeptide activating melanocortin receptors, mainly MC4R. Supplied for research, not as a licensed medicine.
View record and quotationExplore neuropeptide signalling, receptor pharmacology and experimental neuroscience. This collection brings together endogenous peptides and investigational compounds with distinct evidence profiles.
Research materials only. Not for human or animal consumption.
A 10mg lyophilised synthetic cyclic heptapeptide activating melanocortin receptors, mainly MC4R. Supplied for research, not as a licensed medicine.
View record and quotationResearch concerns opioid physiology, pain, stress, receptor pharmacology, analytical standards, animal models, and modified analogues/prodrugs.
Read research recordAn investigational erythropoietin derived peptide with small early phase studies in sarcoidosis associated small fiber neuropathy, diabetic macular oedema and metabolic contexts; no authorised indication has been identified.
Read research recordResearch examines pain, stress/reward, neuroendocrine signaling, and associations with neurological/psychiatric conditions.
Read research recordIt is principally a biochemical and preclinical research model.
Read research recordEvidence is principally preclinical pharmacology and rodent analgesia.
Read research recordResearch concerns opioid signaling, pain and stress biology, neuroinflammation, addiction related processes, and inflammatory/cardiovascular models.
Read research recordEvidence is predominantly cell, animal, and in silico research.
Read research recordIt is an experimental antigen used to induce or study experimental autoimmune encephalomyelitis in susceptible rodents.
Read research recordResearch is biochemical, ex vivo, and rodent analgesia work.
Read research recordResearch comprises recombinant channel assays, neuronal studies, and mouse behavioral/neurogenesis experiments.
Read research recordSmall comparative Russian studies in anxiety/neurasthenia and phobic anxiety and somatoform disorders have been published, alongside animal, receptor, and gene expression work.
Read research recordResearch focuses on neuroprotection, stroke recovery, neurotrophin related signaling, and brain network effects.
Read research recordIt was developed as a non opioid analgesic with clinical trials in severe chronic pain.
Read research record